›Apr 25, 2026phase 1 completion108d agoShenzhen Salubris Pharmaceuticals Co Ltd — (alisartan calcium + amlodipine besylate + sacubitril) (Phase I Trial Completion)(alisartan calcium + amlodipine besylate + sacubitril)

Therapy area: Cardiovascular. Indication: Hypertension

full page →(alisartan calcium + amlodipine besylate + sacubitril) →source: globaldata

›Apr 26, 2026phase 1 2 completion107d agoMahatma Gandhi Ayurved College Hospital and research centre — ayurvedic medicine (Phase I/II Trial Completion)ayurvedic medicine

Therapy area: Cardiovascular. Indication: Thrombophlebitis

full page →ayurvedic medicine →source: globaldata

›Apr 26, 2026phase 2 results107d agoMinistry of Education University and Research, Italy — artichoke (Phase II Trial Results)artichoke

Therapy area: Cardiovascular, Gastrointestinal. Indication: Endothelial Dysfunction, Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD or NAFLD)

full page →artichoke →source: globaldata

›Apr 26, 2026phase 3 completion107d agoTehran University of Medical Sciences — diltiazem (Phase III Trial Completion)diltiazem

Therapy area: Cardiovascular. Indication: Unspecified Cardiovascular Disorders

full page →diltiazem →source: globaldata